CEO Per von Mentzer presented PharmNovo at the BioStock - Connecting Innovation and Capital Life Science Fall Summit 2022. Watch his presentation addressing the large, unmet medical needs in the neuropathic pain market and learn more about our ongoing clinical trial and how we will achieve project milestones as PharmNovo moves forward.
Read more →
The PharmNovo team would like to wish you a Merry Christmas and a Happy New Year!
Read more →PharmNovo has strengthened the team with a new experienced Project Manager and a Clinical Trial Manager
Read more →Read the story about PharmNovo and our drug candidate PN6047 for neurophatic pain and its ongoing phase I studies in Svenska Dagbladet.
Read more →
